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The editorial team for the ‘Science’ section of INNOVATIONS 
in pharmacy is inviting submissions on a wide range of topics. 
Before describing the types of manuscripts that we invite in 
the Science section of the journal, we feel that it is necessary 
to discuss what science, innovation, and the process of 
scientific inquiry are as these principles have guided us in the 
process of determining the types of manuscripts we solicit.   
  
I. Science 
 
By definition, science is the undertaking that seeks to 
understand natural and social phenomena through the 
application of systematic observation, (sometimes) 
experimentation, recording of observations, and analysis of 
these observations.
1,2  These basic steps (or ‘scientific 
method’) allow one to compare intuitions about the state of 
reality to information on its actual functioning. As such, 
science is distinguished from other ways of knowing, such as 
faith and “common sense”. Through the iterative application 
of this process, we are able to refine our understanding of 
pharmacists, patients, and the medication use process, and 
eventually develop and test models and theories that are 
useful for description, prediction and control in the context of 
pharmacy and pharmaceuticals.   
 
Philosophers of science have suggested that science can be 
distinguished from other ways of knowing by three general 
attributes.
3,4 The first of these is a reliance on one’s sense 
impressions, or experiences, of empirical phenomena. 
Although this may seem self-evident, many positions once 
widely accepted as true were later disproved with the aid of 
careful observation. For example, one influential theory in 
the eighteenth century regarding the spread of smallpox was 
that of the ‘epidemic constitution’, which suggested that a 
vague constellation of climactic conditions was responsible 
for the disease’s spread.
5 The second attribute that 
distinguishes science from other ways of knowing is the 
application of rigorous analysis to these sense impressions. 
Quantitative researchers often apply mathematical models in 
these analyses, while qualitative investigators apply an array 
of other techniques to the data they collect as a way of 
understanding the world The final attribute that distinguishes 
science from other ways of knowing is its social structure.
3 
For example, we often rely on scientists working in other 
fields such as economics, sociology, or consumer research 
when we search for models or theories (and the variables 
they suggest) to guide our own research on the medication 
use process. We make use of the institutional nature (i.e. 
annual conferences, academic journals) of our field, as well as 
informal social networks, to help us ‘stand on the shoulders 
of giants’ and improve the knowledge base in our field. It is 
this final attribute of science that the Science section of 
Innovations in Pharmacy hopes to serve in providing a forum 
for innovative, peer-refereed work in our area.  
 
 
II. Innovation 
 
What is innovation? What is it that makes anything in general 
and science in particular, innovative?  Within economics, 
innovation can be defined as the introduction of a new good 
to a market, the application of a new idea to decrease 
production costs, the organization of a firm in a novel way, or 
the opening of a new market for an existing service or 
product.
6,7  That is, the essential criterion of an innovation is 
that of ‘newness’. Specifically, innovation is the application of 
an existing idea to a new situation which is different from 
invention (the discovery of a new idea or knowledge).
8 For 
example, the use of computed tomography (CT) scans to 
screen for colon cancer would be considered an innovation, 
but the development of the first CT scanning machine would 
be termed an invention. In this Science section, our focus is 
on innovation, rather than invention.  
 
Innovations in science are important as they help improve the 
body of knowledge within each discipline and help move 
disciplines forward. Oftentimes, to move disciplines forward, 
researchers and academicians are required to switch from 
the old to more novel ways of approaching problems. Here, 
we explain how innovations impact our disciplines by using 
The Structure of Scientific Revolutions
9 by Kuhn. Kuhn 
developed a general theory of the history and development 
of scientific disciplines that has been termed ‘historical 
relativism’ by some.
10 Kuhn proposed that scientific 
endeavors within a given discipline are dominated by a 
central paradigm, which contains content such as laws, 
concepts, and standard examples of the types of problems 
that the current paradigm is able to address as well as a 
scientific methodology which is used to address the 
problems. The development of scientific disciplines passes 
through three stages.
3  
 Invitation  SCIENCE 
 
http://z.umn.edu/INNOVATIONS                              2010, Vol. 1, No. 1, Article 13                   INNOVATIONS in pharmacy    2 
 
The first of these is the pre-paradigmatic stage in which there 
is little agreement among scientists within the discipline 
regarding the proper methodology to employ and the correct 
manner in which to interpret a collection of observations.
3,9 
During this stage, a number of schools of thought exist until a 
single theory comes to the forefront and attracts a number of 
adherents sufficient that it comes to dominate a field. When 
this occurs, the second, or ‘normal science’ stage begins. It is 
at this point that a single paradigm comes to dominate the 
conduct of science in a discipline because it is viewed as more 
successful at addressing problems than other competitors. 
 
However, investigators working within a field eventually 
begin to note more and more counterexamples, or 
anomalous observations, that cannot easily be explained 
using the predominant paradigm.
9 The existing paradigm is 
increasingly seen as inadequate to address the questions the 
with which the discipline is faced. This phenomenon leads to 
the third or ‘scientific revolution’ stage, in which scientists 
search and evaluate competing paradigms for one that does a 
better job at explaining known phenomena in addition to the 
anomalous observations. When one of these is found, a 
‘paradigm shift’ occurs. Importantly, it is during this period of 
recognition by increasing numbers of practitioners within a 
given field of the inadequacy of a given paradigm during 
which true innovation in a scientific field is able to occur. 
Hence, this ‘Science’ section of the Journal serves as a forum 
for researchers to communicate novel ways of approaching 
and solving health care problems which may lead to a shift in 
paradigm. 
 
III. Innovation in the Science of Pharmacy 
 
A cursory examination of the field of social and administrative 
pharmacy would suggest to most observers that our 
discipline is not dominated by any single paradigm. However, 
our discipline has been fortunate in that it has featured many 
scientists that have been influential enough to ‘change the 
conversation’ among large numbers of us for prolonged 
periods of time by introducing novel theoretical perspectives, 
new methodologies, and/or new perspectives from which to 
view the medication use process. Although these individuals 
are far too numerous to list and discuss, we provide several 
examples of these persons below and the innovations they 
introduced. 
 
For many years, disciplinary perspectives provided by 
economics, marketing and management held sway in social 
and administrative pharmacy.
11 As a result, a significant 
amount of study was devoted to dyadic relationships 
important in the medication use process (e.g. pharmacist – 
patient, pharmacist – technician). Departing from others who 
studied dyadic relationships, Kenneth N. Barker, Ph.D. was 
one of the first scientists in our field to suggest a shifting of 
the focus from this micro-level of study to the system level 
with his pioneering work in the field of medication safety.
12,13 
For example, Dr. Barker introduced and evaluated the unit 
dose medication dispensing system as well as an accurate 
observational method for measuring medication errors in 
institutions. The unit dose system and observation method 
are still in use and continue to have a positive impact on the 
practice of pharmacy.  
 
Further, studies of the structure (e.g. how many outpatient 
pharmacies) and processes (e.g. how patients were 
counseled) were predominant during the discipline’s early 
years. As such, this made the work of J. Lyle Bootman, Ph.D. 
quite novel. Dr. Bootman introduced a focus on economic 
evaluation of outcomes in the medication use process with a 
number of influential articles on the use of cost-effectiveness 
and cost-benefit analysis.
14,15 Interest in the application of 
these techniques to pharmaceutical interventions in both 
academia and the pharmaceutical industry has grown 
steadily, eventually morphing into the discipline known as 
pharmacoeconomics. Today, the importance of these 
techniques is attested to by the fact that the majority of U.S. 
pharmacy schools require significant exposure to 
pharmacoeconomics principles in their professional 
curricula.
16  
 
The last investigator whom we would like to mention in this 
commentary has also made significant contributions in Social 
and Administrative Pharmacy. Trained as a medical 
sociologist, Bonnie Svarstad, PhD, brought a unique 
theoretical perspective to her studies of the medication use 
process. Although Dr. Svarstad has made numerous 
contributions to the field throughout her career, she is 
recognized internationally as an authority on medication 
adherence. Examples of her contributions include 
introduction and elaboration of the Health Communication 
Model
17,18 which describes the effects of health care 
providers’ use of a collaborative communication style on 
client knowledge of and beliefs regarding drug treatment 
regimens and ultimately their satisfaction and adherence to 
these regimens. Dr. Svarstad also has developed innovative 
tools used in this work, such as the Brief Medication 
Questionnaire
19, which is used to screen for medication 
adherence problems and has been applied widely. 
 
IV. The Process of Scientific Inquiry 
 
Thus far, we have discussed how innovations may change 
scientific paradigms and we have also given specific examples 
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section, we discuss the process of scientific inquiry. Two 
approaches to inquiry have dominated scientific 
investigation: these are commonly referred to as quantitative 
and qualitative research methodologies.  These paradigms 
differ in the theoretical orientations that guide them, the 
research questions that are addressed by each, as well as the 
data collection and analysis methods that dominate each of 
these areas of scientific inquiry. 
 
Quantitative research methods often are identified with the 
positivist or empiricist orientations to research, which 
describes the world as being comprised of “measurable 
facts”.
20 Therefore, researchers using quantitative research 
methodologies “quantify” or numerically measure elements 
of interest, often through the use of statistics.  A priori 
hypotheses and theory frequently are the drivers of 
quantitative research.
21 On the other hand, qualitative 
research methods typically are associated with a 
constructivist research orientation in which “reality is socially 
constructed, complex, and ever changing.”
20 In the qualitative 
paradigm, the researcher collects data in a naturalistic 
setting, often using small groups of subjects whose 
perceptions are solicited. The researcher is the “key 
instrument” in the data collection and interpretation/analysis 
process, which usually focuses on words and patterns, rather 
than numbers.
20,
22  Instead of being hypothesis and theory 
driven, researchers using qualitative approaches often use an 
inductive approach in data collection and analysis to generate 
hypotheses and theory which can be tested in future 
research. Examples of qualitative approaches to scientific 
inquiry include focus groups, personal interviews, and field 
research.   
 
A decision to select a quantitative or qualitative method 
depends on the research question being investigated. That is, 
the research question should dictate the type of research 
design employed by the scientist. A researcher using an 
exploratory research design focuses on studying a 
phenomenon of interest and uncovering “ideas and insights” 
about the phenomenon.
22,23 For example, a scientist may 
conduct an exploratory study in a group of patients to discern 
which attributes are important when they form professional 
relationships with pharmacists.  Descriptive research designs 
can be guided by preliminary hypotheses and can be used to 
determine relationships between and among variables of 
interest, or, to determine the frequency with which an 
attribute of interest occurs.
23 Using a descriptive research 
design, a researcher could develop a model of pharmacist-
patient relationships and examine the associations among 
model constructs. 
 
Both exploratory and descriptive research designs can result 
in data that might be used to generate hypotheses for future 
research using experimental research designs. Experimental 
designs are used to determine hypothesis driven causal 
relationships.
24 When this type of design is used, an 
experiment or intervention is implemented to assess the 
effect of the manipulation of at least one independent 
variable on one or more dependent variables. An 
experimental research design could be used to test the effect 
of an intervention designed to increase patient participation 
in the pharmacist-patient relationship and then measure its 
effect on the relationship quality from the patient’s 
viewpoint.  It is important for researchers to consider the 
research question(s) and goals of their study and then choose 
the appropriate design, making sure that their rationale is 
apparent in manuscripts submitted to Innovations in 
Pharmacy.   
 
Regardless of the type of scientific inquiry used, it is 
important for authors to address measures of quality or rigor 
in their research. In this section, we describe measures of 
quality in both quantitative and qualitative research. 
 
Addressing internal and external validity is critical to 
assessing the quality of scientific research. In quantitative 
research the researcher should be concerned with threats to 
internal and external validity.  A study has internal validity if 
the relationship between two or more variables is due to the 
experimental treatment or intervention, and not due to 
extraneous variables or other conditions of the experiment.
8   
Examples of extraneous variables that could confound the 
effect of the intervention (or experiment) if not controlled, 
include the effects of history, maturation, testing, and 
instrumentation.
25  External validity in quantitative research 
refers to the generalizability of the study results to the target 
population of interest. According to Campbell and Stanley
25 
factors such as the interaction effect of testing, the 
interaction effects of selection bias and the experimental 
variable, and the reactive effects of experimental 
arrangements can all limit the generalizability of study 
results.   
 
Quality assessment in qualitative research also is concerned 
with internal and external validity; however, different 
terminology is used to address these issues.  Based on 
differences in qualitative techniques, different methods of 
evaluating quality within this paradigm can be found in the 
literature.  For example, internal validity in qualitative 
research can be measured by credibility.
26  Credibility 
“measures how vivid and faithful the description of the 
phenomenon is.”
27 To evaluate credibility, the research 
design, as it relates to data collection and analysis, must be Invitation  SCIENCE 
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critiqued.  Fittingness is a term used in the qualitative 
research paradigm to address external validity. Guba and 
Lincoln
26  state that “fittingness measures how well the 
working hypotheses or propositions fit into a context other 
than the one from which they were generated.”  Based on 
this definition, fittingness is analogous to generalizability. 
 
Quality assessment also must focus on the reliability and 
validity of the instruments used in the data collection 
process.  Internal-consistency reliability is defined as 
consistency of measurement,
8 and often is used to assess 
reliability of multi-item, latent constructs. Examples of 
common methods to determine internal-consistency 
reliability include Cronbach’s coefficient alpha, Kuder-
Richardson-20, and the split-half procedure.
22  Auditability is 
the term that is used to assess consistency (reliability) in 
qualitative research.
26, 27  Specifically, auditability has been 
defined as “the ability of another investigator to follow the 
decision or audit trail”. Evaluation of auditability in qualitative 
research typically focuses on how data were analyzed.
27  The 
validity of an instrument refers to whether or not the data 
collection instrument is accurately measuring what it is 
intended to measure. Types of validity include content or face 
validity, construct validity and criterion-related validity.
22, 23 
 
A detailed description of the threats to internal and external 
validity is beyond the scope of this paper.  However, 
researchers submitting papers to the Science section of 
Innovations in Pharmacy are encouraged to discuss threats to 
internal and external validity as they apply to their research 
design and the type of research conducted (quantitative or 
qualitative).  If appropriate, a discussion of the manner in 
which these threats were minimized (e.g. for quantitative 
research, randomization, statistical control for certain 
variables, etc.) should be included in the manuscript to make 
it clear to the reader that appropriate steps were taken to 
help ensure the quality of the research.  If further threats to 
internal and/or external validity exist in the study, then the 
researcher(s) should acknowledge these in the ‘Limitations’ 
section of their manuscript.  Similarly, an author submitting a 
paper to this journal in which a data collection instrument 
was developed or used should clearly provide data to support 
assertions of reliability and validity.  
 
In summary, we encourage journal submissions from 
researchers who use a quantitative or qualitative approach, 
or, a combination of both approaches.  Regardless of the type 
of scientific inquiry used, it is important for authors to 
address measures of quality or rigor in their research.  These 
processes should be transparent and clearly described in 
manuscript submissions.   
 
V. Innovation Section: Scope and Type of Manuscripts 
 
V. 1 Scope 
The aim of the Science section is to advance pharmacy 
practice and health care through empirical investigation and 
theoretical analysis. The Science section provides an 
international and interdisciplinary forum for the 
dissemination and discussion of research related to health, 
health care practitioners, health care institutions, and/or 
health care systems. We are receptive to research across a 
broad range of health care and pharmacy practice topics such 
as implementation and dissemination of advanced patient 
care services, patient and provider education, patient-
provider communications, pharmacy management and 
leadership, pharmacoeconomics, comparative effectiveness 
and marketing. Contributions can be grounded in various 
social science disciplines including economics, 
communication, psychology, sociology, management sciences 
and education. All empirical methods are invited including 
qualitative, quantitative, and mixed methods. A key feature 
of this journal is a mix of theoretically driven articles, 
methodology articles, and research articles exploring 
emerging health care and pharmacy practice topics. It thus 
addresses an audience of researchers as well as practitioners 
who seek to advance pharmacy practice and health care.  
 
V. 2 Type of Manuscripts 
Manuscripts submitted to our Section can be empirical, 
conceptual or methodology oriented. Empirical manuscripts 
should use rigorous research designs to address gaps in 
existing literature. Well-articulated and strong theoretical 
foundations in empirical manuscripts are strongly 
encouraged. Conceptual manuscripts should provide new 
theoretical insights that can advance our understanding of 
issues with high importance for pharmacy practice and health 
care. It should be noted that a review article that simply 
reports research previously conducted but fails to provide 
new insights will not be considered. Further, we aim to 
promote the scientific development of health care and 
pharmacy practice research. Hence, we invite research 
articles that focus on examining methodological approaches 
for more rigorous scientific results in the social sciences. That 
is, manuscripts that address methodology problems in 
empirical research, including research design, data collection, 
measurement, and data analysis are encouraged. 
Manuscripts that focus on the methodological problems 
involved in any approach used in empirical research are also 
appropriate. Finally, we encourage submission of 
"replication" studies and also the submission of research 
reports presenting "non-statistically significant findings." 
These findings are important for scientific inquiry and for 
making progress in a field. Invitation  SCIENCE 
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VI. A Call for Papers 
 
The editorial team welcomes submissions to the Science 
section of the INNOVATIONS in pharmacy. We encourage 
submissions exploring a variety of health care-related topics 
from all perspectives and all types of scientific inquiry. The 
significance of the issue of interest, the novelty of the 
approach used, and the measures of quality and rigor in their 
research should be transparent and clearly communicated. 
We are looking forward to receiving your submissions and we 
thank you for considering INNOVATIONS in Pharmacy as a 
channel for disseminating your work to further advance 
pharmacy practice and health care systems. 
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